You are here: Home: CME-Certified Case-Based Satellite Symposia

Meet the Professors
A Case-Based Panel Discussion on Management of Metastatic Breast Cancer

Target Audience
This activity has been designed to meet the educational needs of oncologists, surgeons and radiation therapists involved in the management of women with breast cancer.

Statement of Need/Program Overview
The rapidly evolving database of clinical trial results in metastatic breast cancer has brought to light a number of questions with regard to optimal management of patients with advanced disease. Patterns of care data indicate a clear lack of uniformity regarding the selection, sequencing, dosing and scheduling of agents. Community oncologists present challenging cases of women with metastatic breast cancer to a panel of research leaders, who will address patient selection for single-agent and combination chemotherapy, optimal sequencing of treatment, treatment of the elderly, choice of hormonal versus cytotoxic agents in ER-positive disease and management of HER2-positive patients.

Educational Objectives
Upon completion of this activity, participants should be able to:

Identify patients with metastatic breast cancer for whom single-agent versus combination therapy would be appropriate to counsel them regarding potential treatment options.
Describe the optimal sequence of single-agent chemotherapies for patient subgroups.
Distinguish the risk/benefit profiles of chemotherapeutic agents/regimens to determine a management algorithm for women with metastatic breast cancer.

Faculty & Affiliations
Stephen E Jones, MD
Director, Breast Cancer Research,
Charles A Sammons Cancer Center,
Baylor University Medical Center

Chair, US Oncology Breast Cancer Research

Clinical Professor, University of Texas Southwestern


Peter Ravdin, MD, PhD
Associate Professor of Medicine,
Division of Medical Oncology,
Department of Medicine,
The University of Texas Health Science Center at San Antonio


Charles L Vogel, MD, FACP, PA

Clinical Professor,
Sylvester Comprehensive Cancer Center,
University of Miami School of Medicine

Community Panel
Jacob D Bitran, MD, FACP, FCCP
Director, Division of Hematology/Oncology,
Lutheran General Hospital


Kathleen A Havlin, MD
Assistant Professor of Medicine,
Feinberg School of Medicine,
Northwestern University


Patricia Madej, MD
Hinsdale Hematology Oncology
Hinsdale, Illinois

Accreditation Statement
NL Communications Inc is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
NL Communications Inc designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent on the activity.

Commercial Support
This program is supported by an education grant from Roche Laboratories Inc.

Faculty Disclosure Statement
As a provider accredited by the ACCME, it is the policy of NL Communications Inc to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty and community panel reported the following:

Stephen E Jones, MD
Consultant: Roche Laboratories Inc, AstraZeneca Pharmaceuticals LP, Pharmacia Corporation

Speakers Bureau: Roche Laboratories Inc, AstraZeneca Pharmaceuticals LP, Pharmacia Corporation, Novartis Pharmaceuticals Corporation


Peter Ravdin, MD
Consultant/Speakers Bureau: Pharmacia Corporation


Charles L Vogel, MD, FACP, PA
Grants/Research Support: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, GlaxoSmithKline, Genentech Inc
Consultant: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Genentech Inc
Speakers Bureau: GlaxoSmithKline, Genentech Inc


Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.). Please contact Arai Penate prior to the live event at 1-800-648-8654 or email: apenate@researchtopractice.net


 
Home · Contact us
Terms of use and general disclaimer
© NL Communications, Inc. 2003. All rights reserved.